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Introduction
Recent evidence suggests that the failure of the immune
system to eradicate cancer cells is due to the tumor co-
opting the normal regulatory/suppressive and homeostatic
mechanisms of the immune system, thus avoiding
immune based destruction. A small percentage of patients
with complete responses (CR; no evidence of tumor) result
from many systemic therapies. CR’s usually underpin long-
term survival.
Methods
Data from numerous studies using standard chemo-
therapy, targeted therapies and immune modulatory thera-
pies were mathematically analysed, using meta-analysis
(M-A) techniques, to evaluate the Complete Response
(CR) Rates.
Results
68 studies using standard chemotherapy for 13 cancer
types treated with 8 drug classes were analysed by meta-
analysis and showed a CR rate of 7.4%. A range of targeted
therapies (B-raf; Mek) and immune based therapies
(CTLA-4; PD-1; PD-L1) were also assessed which showed
similar findings. Meta-analysis of 62 IL-2 based therapies
showed a similar CR rate also. Over 8000 patients were
examined across the meta-analyses.
Conclusions
Mathematical analyses of over 130 clinical trials, inclusive
of over 8000 patients, has demonstrated that the CR rate
for patients treated with widely divergent therapies is
remarkably fixed at between 5 and 10%. The probability
of this occurring by chance alone is extremely close to
zero, and is both scientifically and clinically implausible.
Therefore, an underlying predictive operative biological
mechanism must apply. It is highly likely that the known
principles of immune kinetics between effector and regu-
latory homeostatic functions must therefore determine a
degree of immune synchronization to produce these
observed CR’s. We have derived a mathematical model
and equation using the principles of controlled homeo-
static systems, which can be used to explain our meta-
analysis findings, and the clinical efficacy.
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